Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 6131 | 1461 | 29.9 | 61% |
Classes in level above (level 2) |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | VALPROIC ACID | Author keyword | 45 | 15% | 18% | 269 |
| 2 | VALPROATE | Author keyword | 27 | 14% | 12% | 181 |
| 3 | TRANS 2 EN VALPROATE | Author keyword | 18 | 89% | 1% | 8 |
| 4 | VALPROATE ENCEPHALOPATHY | Author keyword | 9 | 83% | 0% | 5 |
| 5 | 2 PROPYL 4 PENTENOIC ACID | Author keyword | 6 | 100% | 0% | 4 |
| 6 | VALPROIC ACID INTOXICATION | Author keyword | 6 | 100% | 0% | 4 |
| 7 | VALPROATE METABOLISM | Author keyword | 4 | 75% | 0% | 3 |
| 8 | SODIUM VALPROATE | Author keyword | 4 | 11% | 2% | 35 |
| 9 | CLIN CHEM PAEDIAT | Address | 4 | 46% | 0% | 6 |
| 10 | 4 ENE VPA | Author keyword | 3 | 100% | 0% | 3 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | VALPROIC ACID | 45 | 15% | 18% | 269 | Search VALPROIC+ACID | Search VALPROIC+ACID |
| 2 | VALPROATE | 27 | 14% | 12% | 181 | Search VALPROATE | Search VALPROATE |
| 3 | TRANS 2 EN VALPROATE | 18 | 89% | 1% | 8 | Search TRANS+2+EN+VALPROATE | Search TRANS+2+EN+VALPROATE |
| 4 | VALPROATE ENCEPHALOPATHY | 9 | 83% | 0% | 5 | Search VALPROATE+ENCEPHALOPATHY | Search VALPROATE+ENCEPHALOPATHY |
| 5 | 2 PROPYL 4 PENTENOIC ACID | 6 | 100% | 0% | 4 | Search 2+PROPYL+4+PENTENOIC+ACID | Search 2+PROPYL+4+PENTENOIC+ACID |
| 6 | VALPROIC ACID INTOXICATION | 6 | 100% | 0% | 4 | Search VALPROIC+ACID+INTOXICATION | Search VALPROIC+ACID+INTOXICATION |
| 7 | VALPROATE METABOLISM | 4 | 75% | 0% | 3 | Search VALPROATE+METABOLISM | Search VALPROATE+METABOLISM |
| 8 | SODIUM VALPROATE | 4 | 11% | 2% | 35 | Search SODIUM+VALPROATE | Search SODIUM+VALPROATE |
| 9 | 4 ENE VPA | 3 | 100% | 0% | 3 | Search 4+ENE+VPA | Search 4+ENE+VPA |
| 10 | VALPROATE METABOLITES | 3 | 100% | 0% | 3 | Search VALPROATE+METABOLITES | Search VALPROATE+METABOLITES |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | 2 NORMAL PROPYL 4 PENTENOIC ACID | 73 | 85% | 3% | 39 |
| 2 | SODIUM VALPROATE | 53 | 17% | 19% | 283 |
| 3 | HEPATIC FATALITIES | 36 | 83% | 1% | 20 |
| 4 | ACID INDUCED HYPERAMMONEMIA | 34 | 93% | 1% | 13 |
| 5 | SECONDARY HYPERAMMONEMIA | 23 | 86% | 1% | 12 |
| 6 | E 2 PROPYL 2 4 PENTADIENOIC ACID | 23 | 100% | 1% | 10 |
| 7 | SERUM CARNITINE | 21 | 57% | 2% | 25 |
| 8 | ASYMPTOMATIC HYPERAMMONEMIA | 21 | 85% | 1% | 11 |
| 9 | DIPROPYLACETATE | 14 | 100% | 0% | 7 |
| 10 | INDUCED HYPERAMMONEMIA | 12 | 40% | 2% | 23 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| Carnitine in the treatment of valproic acid-induced toxicity | 2009 | 63 | 79 | 92% |
| Valproate: A reappraisal of its pharmacodynamic properties and mechanisms of action | 1999 | 298 | 169 | 49% |
| Valproate-induced hyperammonemic encephalopathy: a brief review | 2012 | 12 | 14 | 93% |
| Evidence for a potential protective effect of carnitine-pantothenic acid co-treatment on valproic acid-induced hepatotoxicity | 2014 | 3 | 48 | 50% |
| Science review: Carnitine in the treatment of valproic acid-induced toxicity - what is the evidence? | 2005 | 63 | 63 | 89% |
| Basic pharmacology of valproate - A review after 35 years of clinical use for the treatment of epilepsy | 2002 | 256 | 131 | 38% |
| Valproate-induced hyperammonemic encephalopathy | 2006 | 66 | 29 | 72% |
| The role of carnitine supplementation during valproic acid therapy | 2000 | 65 | 22 | 95% |
| The effects of sodium valproate on the renal function of children with epilepsy | 2014 | 1 | 30 | 70% |
| L-Carnitine for Acute Valproic Acid Overdose: A Systematic Review of Published Cases | 2010 | 14 | 13 | 77% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | CLIN CHEM PAEDIAT | 4 | 46% | 0.4% | 6 |
| 2 | TOXICOGENOM CONSORTIUM | 2 | 67% | 0.1% | 2 |
| 3 | ACUTE POISONING UNIT | 1 | 33% | 0.1% | 2 |
| 4 | BEERS MURPHY CLIN NUTR | 1 | 50% | 0.1% | 1 |
| 5 | BEREICH HAMATOL ONKOL HAMOSTASEOL | 1 | 50% | 0.1% | 1 |
| 6 | BIPOLAR DISORDERS UNITIDIB SCIBERSAM | 1 | 50% | 0.1% | 1 |
| 7 | EPILEPSY ENCEPHALOG UNIT | 1 | 50% | 0.1% | 1 |
| 8 | GENER ARD | 1 | 50% | 0.1% | 1 |
| 9 | GIFU UNIV HOSP | 1 | 50% | 0.1% | 1 |
| 10 | HALL PSYCHIAT | 1 | 50% | 0.1% | 1 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000151061 | CARBAMAZEPINE 10 11 EPOXIDE//FREE PHENYTOIN//R 4PK |
| 2 | 0.0000089413 | GENIUS R//CHARCOAL HEMOPERFUSION//CARBAMAZEPINE INTOXICATION |
| 3 | 0.0000087810 | AUDITORY DISTURBANCE//PERIPHERAL NEUROMUSCULAR FUNCTION//ACUTE FORM |
| 4 | 0.0000071970 | HARVARD NEUROENDOCRINE UNIT//CATAMENIAL EPILEPSY//HYPOSEXUALITY |
| 5 | 0.0000068901 | EXPTL EPILEPSIEFOR//EXPERIMENTAL EPILEPSY MODELS//MODEL NERVOUS SYSTEM |
| 6 | 0.0000067608 | LAMOTRIGINE//FELBAMATE//OXCARBAZEPINE |
| 7 | 0.0000066940 | ANTICONVULSANT ACTIVITY//MES TEST//EPILEPSY BRANCH |
| 8 | 0.0000062953 | EMORY EPILEPSY PROGRAM//KERALA REGISTRY EPILEPSY PREGNANCY//FETAL HYDANTOIN SYNDROME |
| 9 | 0.0000061766 | REYES SYNDROME//REYE SYNDROME//HLTH SCI MED COMPARAT MED |
| 10 | 0.0000054298 | GABAA RECEPTOR CHLORIDE IONOPHORE COMPLEX//CEREBROSPINAL FLUID AND PLASMA LEVELS//FENGABINE |